Issue 2/2012
Content (41 Articles)
The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer
Dulcinea Candelaria-Quintana, Zoneddy R. Dayao, Melanie E. Royce
A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance
Catherine Meads, Ikhlaaq Ahmed, Richard D. Riley
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH
Simon A. Joosse, Kim I. M. Brandwijk, Peter Devilee, Jelle Wesseling, Frans B. L. Hogervorst, Senno Verhoef, Petra M. Nederlof
KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer
Muralidharan Anbalagan, Latonya Carrier, Seth Glodowski, David Hangauer, Bin Shan, Brian G. Rowan
Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells
Jouko Sandholm, Joonas H. Kauppila, Christine Pressey, Johanna Tuomela, Arja Jukkola-Vuorinen, Markku Vaarala, Martin R. Johnson, Kevin W. Harris, Katri S. Selander
Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer
Juan Zhang, Renguang Pei, Zhiyuan Pang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie
Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression
Sharon Hensley Alford, Katherine Toy, Sofia D. Merajver, Celina G. Kleer
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
Jord H. A. Nagel, Justine K. Peeters, Marcel Smid, Anieta M. Sieuwerts, Marijke Wasielewski, Vanja de Weerd, Anita M. A. C. Trapman-Jansen, Ans van den Ouweland, Hennie Brüggenwirth, Wilfred F. J. van IJcken, Jan G. M. Klijn, Peter J. van der Spek, John A. Foekens, John W. M. Martens, Mieke Schutte, Hanne Meijers-Heijboer
The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells
Hagai Ligumsky, Ido Wolf, Shira Israeli, Michal Haimsohn, Sarah Ferber, Avraham Karasik, Bella Kaufman, Tami Rubinek
In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer
Melanie Spears, Karen J. Taylor, Alison F. Munro, Carrie A. Cunningham, Elizabeth A. Mallon, Chris J. Twelves, David A. Cameron, Jeremy Thomas, John M. S. Bartlett
Bone metastasis in a novel breast cancer mouse model containing human breast and human bone
Tian-Song Xia, Guo-Zhu Wang, Qiang Ding, Xiao-An Liu, Wen-Bin Zhou, Yi-Fen Zhang, Xiao-Ming Zha, Qing Du, Xiao-Jian Ni, Jue Wang, Su-Yu Miao, Shui Wang
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways
Catherine Ibarra-Drendall, Michelle M. Troch, William T. Barry, Gloria Broadwater, Emanuel F. Petricoin III, Julia Wulfkuhle, Lance A. Liotta, Siya Lem, Joseph C. Baker Jr., Anne C. Ford, Lee G. Wilke, Carola Zalles, Nicole M. Kuderer, Abigail W. Hoffman, Melanie Shivraj, Priya Mehta, Jamila Williams, Nora Tolbert, Laurie W. Lee, Patrick G. Pilie, Dihua Yu, Victoria L. Seewaldt
A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity
Ensel Oh, Yoon-La Choi, Taesung Park, Seungyeoun Lee, Seok Jin Nam, Young Kee Shin
ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer
Jeanette Dupont Jensen, Ann Knoop, Marianne Ewertz, Anne-Vibeke Laenkholm
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
J. Chuck Harrell, Aleix Prat, Joel S. Parker, Cheng Fan, Xiaping He, Lisa Carey, Carey Anders, Matthew Ewend, Charles M. Perou
LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome
Justin Stebbing, Aleksandra Filipovic, Ian O. Ellis, Andrew R. Green, Tanya Rapoz D’Silva, Heinz-Josef Lenz, R. Charles Coombes, Tingting Wang, Soo-Chin Lee, Georgios Giamas
The prognostic significance of B lymphocytes in invasive carcinoma of the breast
S. M. A. Mahmoud, A. H. S. Lee, E. C. Paish, R. D. Macmillan, I. O. Ellis, A. R. Green
The anatomy of fluid-yielding ducts in breast cancer
Dominique Twelves, Ashutosh Nerurkar, Peter Osin, Ann Ward, Clare M. Isacke, Gerald P. H. Gui
Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer
Cecilia L. Speyer, Jennifer S. Smith, Malathi Banda, John A. DeVries, Tassia Mekani, David H. Gorski
Targeting low molecular weight cyclin E (LMW-E) in breast cancer
Angela Nanos-Webb, Natalie A. Jabbour, Asha S. Multani, Hannah Wingate, Nassima Oumata, Hervé Galons, Benoît Joseph, Laurent Meijer, Kelly K. Hunt, Khandan Keyomarsi
Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01
Seock-Ah Im, Keun Seok Lee, Jungsil Ro, Eun Sook Lee, Youngmee Kwon, Jin-Hee Ahn, Jin Seok Ahn, Jee Hyun Kim, Han Sung Kang, Kyung Hwan Shin, Dong-Young Noh, In-Ae Park, Sung-Bae Kim, Young Hyuck Im, Sung Whan Ha
Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors
Albane Frati, Elisabeth Chereau, Charles Coutant, Corinne Bezu, Martine Antoine, Jocelyne Chopier, Emile Daraï, Serge Uzan, Joseph Gligorov, Roman Rouzier
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial
Helen Gogas, Urania Dafni, Maria Karina, Christos Papadimitriou, Anna Batistatou, Mattheos Bobos, Haralabos P. Kalofonos, Anastasia G. Eleftheraki, Eleni Timotheadou, Dimitrios Bafaloukos, Christos Christodoulou, Christos Markopoulos, Evangelos Briasoulis, Pavlos Papakostas, Epaminontas Samantas, Paris Kosmidis, George P. Stathopoulos, Charisios Karanikiotis, Dimitrios Pectasides, Meletios A. Dimopoulos, George Fountzilas
Absence of ectopic epithelial inclusions in 3,904 axillary lymph nodes examined in sentinel technique
Sonja Iken, Marcus Schmidt, Claudia Braun, Antonietta Valentino, Hans-Anton Lehr, Stephan C. Schaefer
Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole
Shalini Singh, Jack Cuzick, David Mesher, Bill Richmond, Anthony Howell
Outcomes of a weight loss intervention among rural breast cancer survivors
Christie A. Befort, Jennifer R. Klemp, Heather L. Austin, Michael G. Perri, Kathryn H. Schmitz, Debra K. Sullivan, Carol J. Fabian
Cadherin–catenin complex dissociation in lobular neoplasia of the breast
Mary Morrogh, Victor P. Andrade, Dilip Giri, Rita A. Sakr, Wooyul Paik, Li Xuan Qin, Crispinita D. Arroyo, Edi Brogi, Monica Morrow, Tari A. King
Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation
Karine Chung, Linda J. Hovanessian-Larsen, Debra Hawes, DeShawn Taylor, Susan Downey, Darcy V. Spicer, Frank Z. Stanczyk, Sherfaraz Patel, A. Rebecca Anderson, Malcolm C. Pike, Anna H. Wu, Celeste Leigh Pearce
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study
Pamela Guglielmini, Alessandra Rubagotti, Francesco Boccardo
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?
Shiri Bernholtz, Yael Laitman, Bella Kaufman, Shnai Shimon-Paluch, Eitan Friedman
Surgical treatment of early stage breast cancer in elderly: an international comparison
M. Kiderlen, E. Bastiaannet, P. M. Walsh, N. L. Keating, S. Schrodi, J. Engel, W. van de Water, S. M. Ess, L. van Eycken, A. Miranda, L. de Munck, C. J. H. van de Velde, A. J. M. de Craen, G. J. Liefers
Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.
Dana E. Rollison, Ashley L. Cole, Ko-Hui Tung, Martha L. Slattery, Kathy B. Baumgartner, Tim Byers, Roger K. Wolff, Anna R. Giuliano
Melatonin pathway genes and breast cancer risk among Chinese women
Sandra L. Deming, Wei Lu, Alicia Beeghly-Fadiel, Ying Zheng, Qiuyin Cai, Jirong Long, Xiao Ou Shu, Yu-Tang Gao, Wei Zheng
Multilevel determinants of breast cancer survival: association with geographic remoteness and area-level socioeconomic disadvantage
Paramita Dasgupta, Peter D. Baade, Joanne F. Aitken, Gavin Turrell
A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population
Aiko Sueta, Hidemi Ito, Takakazu Kawase, Kaoru Hirose, Satoyo Hosono, Yasushi Yatabe, Kazuo Tajima, Hideo Tanaka, Hiroji Iwata, Hirotaka Iwase, Keitaro Matsuo
Risk of breast cancer in families of multiple affected women and men
Melanie Bevier, Kristina Sundquist, Kari Hemminki
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project
Marilyn L. Kwan, Wendy Y. Chen, Candyce H. Kroenke, Erin K. Weltzien, Jeannette M. Beasley, Sarah J. Nechuta, Elizabeth M. Poole, Wei Lu, Michelle D. Holmes, Charles P. Quesenberry Jr., John P. Pierce, Xiao Ou Shu, Bette J. Caan
Genetic variants at chromosome 9p21, 10p15 and 10q22 and breast cancer susceptibility in a Chinese population
Jiaping Chen, Yue Jiang, Xiaoan Liu, Zhenzhen Qin, Juncheng Dai, Guangfu Jin, Hongxia Ma, Shui Wang, Xinru Wang, Zhibin Hu, Hongbing Shen
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer
Alberto J. Montero, Kiran Avancha, Stefan Glück, Gilberto Lopes
Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin
Robert C. G. Martin, Ken Robbins, Joan Falcó Fagés, Francisco Diaz Romero, Lisa Rustein, Dana Tomalty, Ricardo Monaco
Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts
Kevin C. Knower, Sarah Q. To, Kiyoshi Takagi, Yasuhiro Miki, Hironobu Sasano, Evan R. Simpson, Colin D. Clyne